Mark Baum Net Worth & Insider Trades

Mark Baum - Director, Eton Pharmaceuticals, Inc

As of March 16, 2020

What is Mark Baum's Net Worth?

The current estimated net worth of Eton Pharmaceuticals, Inc's Director, Mark Baum, is estimated to be about $6.89M . Mark Baum owns about 794,745 units of Eton Pharmaceuticals, Inc common stock. In the last 2 years at Eton Pharmaceuticals, Inc, Mark Baum has sold an estimated value of $0 worth.

What is Mark Baum's Past Insider Trading?

Mark Baum's largest purchase order was 10,000 units , worth over $60K on November 15, 2018. In total, Mark Baum has made about 3 transactions over 2 years of their time at Eton Pharmaceuticals, Inc. Mark Baum usually trades in March, with the busiest year in 2020, 2019 and 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Mark Baum's' Mailing Address?

  • Mailing address is C/o Imprimis Pharmaceuticals, Inc 12264 el Camino Real, Suite 350 San Diego CA 92130 CA

Eton Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Stock Awards
Option Awards
Other Compensation
Total
Sean E. Brynjelsen 2020 $475,833 $218,700 - $1,305,360 $11,400 $2,011,293
Sean E. Brynjelsen 2019 $409,958 $186,500 - $1,338,750 $11,200 $1,946,408
W. Wilson Troutman 2020 $277,083 $108,000 - $509,629 $11,400 $906,112
W. Wilson Troutman 2019 $242,667 $87,500 - $523,260 $11,200 $864,627
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1710340/000149315221009679/formdef14a.htm

What are Eton Pharmaceuticals, Inc's Past Insider Trades?

Eton Pharmaceuticals, Inc's most recent insider trade came on September 23, 2022 by Sean Brynjelsen who bought 10,000 units worth $21.04K . In the last 4 years, insiders at Eton Pharmaceuticals, Inc have sold an estimated value of $20.77M and bought an estimated value of $3.29M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Sean Brynjelsen, Chief Executive Officer,  Opaleye Management Inc,  and Charles Casamento, Director .

Eton Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1